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The purpose of this study was the search of new biomar-
kers for preventive and personalized therapy of cancer.
Thiol-disulfide system was selected as a target for drug
screening as the most important biochemical system that
characterizes the state of the antioxidant defense and
redox processes. The study involved more than 1,200
patients with chronic hepatitis C (HCV), genital herpes,
human papillomavirus infection, endometriosis, non-small
cell lung cancer (NSCLC), metastatic kidney and prostate
cancer. An original method for screening drug prepara-
tions was proposed, where whole blood with anticoagulant
(EDTA) was incubated in thermostat (37°C) in the pre-
sence of drugs for 1 h, the control samples incubated with
saline [1]. Determination of SH-and SS-groups in hemoly-
sate was done by spectrophotometry. In processing the
data performance SH-groups and SH/SS ratio in the con-
trol and experimental samples were compared. It was
found that all medications, including cytostatic, hormonal,
antiviral and immune have either a stimulating or a
depressing effect on blood thiol-disulfide system, by which
one can predict the efficacy and safety of therapy, and to
individualize treatment [2-4]. In two controlled studies a
3-fold increase in the incidence of virological response of
personalized monotherapy with interferon (IFN) of HCV
patients was shown, and the rate of adverse effects was
decreased by 6 times compared with standard IFN ther-
apy. Prognostic significance of SH/SS -test for the treat-
ment of HCV patients was 89.8% [3]. Control studies also
demonstrated a 2-fold increase in the efficiency of perso-
nalized hormonal therapy of endometriosis compared with
standard and a 2-fold increase in the frequency of partial
remission rate of NSCLC after personalized treatment by
cytostatics compared with standard chemotherapy [4].
Thus, the thiol-disulfide system can be regarded as a
universal biomarker for preventive and personalized ther-
apy of cancer. The proposed method of drugs screening
using SH/SS-test can be used to personalize therapy of
viral diseases and cancer by hormonal, antiviral, cytostatic
and immune preparations to improve efficiency and over-
come resistance to drugs, finding the best drugs, their
doses and combinations, reducing the frequency of side
effects and complications to prevent cancer, its relapse
and progression.
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